








The DEA has filed an intent to schedule MGM-15, MGM-16, and some various other alkaloids and chemicals in 30 days from July 6th as well as possibly scheduling or heavily regulating 7-Hydroxymitragynine. As it stands, these products will be removed from our website on August 6th. However, that is not a 100% confirmed date as there could be another 30-90 day grace period after August 6th or changes may come up that hinder the scheduling in one way or another. We cannot say for certain either way, all we can currently do is pass on all relevant news to our customers so that they may prepare. We will provide rolling updates on affected product's pages on our website regularly, so check back here every few days for any new updates. At minimum; up until August 6th this product will remain up for sale.
Are you 21 years old or older?
Sorry, the content of this store can't be seen by a younger audience. Come back when you're older.















7Find true relaxation with the 7EN 7-Hydroxy 10mg Kratom Tablets! With 30mg of pure 7-Hydroxy in each pack and 3 delicious flavors to choose from, the 7EN Hydroxy tablets will help you find peace!
From the masterminds of the best-selling Road Trip Gummies, the 7EN Hydroxy Kratom tablets are set to become a best seller!
By maximizing purity and taste without breaking your wallet, 7EN 7 Hydroxy Kratom Tablets will exceed your expectations!
Shop for Wholesale 7 Hydroxy Tablets
Customers who have enjoyed our other 7-Hydroxy products should definitely try this great new product.
7-Hydroxy-mitragynine is a naturally occurring alkaloid found in the leaves of *Mitragyna speciosa*, commonly known as kratom, a tree native to Southeast Asia. It is a metabolite of mitragynine, the primary active compound in kratom. It is considered significantly more potent in its interaction with the body’s opioid receptors. This potency makes it one of the key contributors to the analgesic and sedative effects associated with kratom use.
Chemically, 7-hydroxy-mitragynine is classified as a partial agonist of the μ-opioid receptor. This means it binds to these receptors and activates them to produce effects similar to opioids, such as pain relief and euphoria.
It is estimated to be several times more potent than morphine and mitragynine, which amplifies its therapeutic potential. However, the extent of respiratory depression compared to traditional opioids appears to be less.
The compound is of interest in pharmacology because of its dual nature—it holds promise as an alternative for managing chronic pain, potentially reducing dependency on synthetic opioids.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare professional before use.